Inhibitors | Comment | Organism | Structure |
---|---|---|---|
LY294002 | treatment inhibits SARS-CoV S-mediated entry into VeroE6 cells | Chlorocebus sabaeus | |
Wortmannin | treatment inhibits SARS-CoV S-mediated entry into VeroE6 cells | Chlorocebus sabaeus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Chlorocebus sabaeus | - |
- |
- |
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
HEK-293 cell | - |
Homo sapiens | - |
Vero-E6 cell | - |
Chlorocebus sabaeus | - |
Synonyms | Comment | Organism |
---|---|---|
phosphatidylinositol 4-kinase IIIbeta | - |
Homo sapiens |
phosphatidylinositol 4-kinase IIIbeta | - |
Chlorocebus sabaeus |
General Information | Comment | Organism |
---|---|---|
malfunction | knockdown of isozyme phosphatidylinositol 4-kinase IIIbeta inhibits SARS-CoV S-mediated entry into VeroE6 cells | Chlorocebus sabaeus |
physiological function | isozyme phosphatidylinositol 4-kinase IIIbeta is required for severe acute respiratory syndrome coronavirus spike-mediated cell entry, overview | Chlorocebus sabaeus |
physiological function | isozyme phosphatidylinositol 4-kinase IIIbeta is required for severe acute respiratory syndrome coronavirus spike-mediated cell entry. PI4P plays an essential role in SARS-CoV spike-mediated entry, which is regulated by the PI4P lipid microenvironment, overview | Homo sapiens |